Forus raises $150M at a $3B valuation, four months after hitting $1B
Sahir Jaggi's medication-access startup is using a free provider-and-patient product to build a distribution network, with Bain Capital Ventures leading the Series C.
By RuntimeWire Staff · Published
Primary source: Bloomberg Technology
Why it matters
Forus is testing whether a healthcare AI company can give its provider product away, use venture capital to capture distribution and monetize the resulting network through drugmakers. The $3 billion valuation prices that model for rapid growth before its customer concentration and contract economics are visible publicly.
Sahir Jaggi (@sahirjaggi) has raised $150 million for Forus at a $3 billion valuation, tripling Forus's reported value roughly four months after its previous financing. Bloomberg reported Tuesday that Bain Capital Ventures led the Series C, with Accel, Thrive Capital, General Catalyst, Redpoint Ventures, BoxGroup and Pear VC participating.…
When you purchase through links in our articles, we may earn a small commission. This doesn’t affect our editorial independence.